Demand for Dengue Vaccines in USA

Future Market Insights

Key Insight

The demand for dengue vaccines in USA is projected to grow from USD 31.0 million in 2025 to USD 66.2 million by 2035, at a CAGR of 7.9%. Qdenga will dominate with a 52.0% market share, while paediatric will lead the age group segment with a 65.0% share.

December 12, 2025

Anurag Sharma

250 Pages

Cite this Report

Demand for Dengue Vaccines in USA

https://www.futuremarketinsights.com/reports/united-states-dengue-vaccines-market

License

Starting at US$ 5000

Buy Now

Summary ToC Companies

Key Players

Codagenix Inc
Emergent BioSolutions Inc
GSK Vaccines
Merck KGaA
Sanofi Pasteur Limited

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

Demand for Dengue Vaccines in USA

Key Players

Similar Industry Reports